Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
India flag India · Delayed Price · Currency is INR
153.09
-0.84 (-0.55%)
Aug 21, 2026, 3:29 PM IST

Nath Bio-Genes (India) Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
416.3386396.19350.11-673.85
Depreciation & Amortization
39.6437.8332.6130.1230.84
Other Amortization
-0.33---
Loss (Gain) From Sale of Assets
-0.0210.35-0.010.01-0.04
Provision & Write-off of Bad Debts
39.0816.522.41.174.5
Other Operating Activities
70.9774.3283.8100.38998.3
Change in Accounts Receivable
-4.2137.5627.65-118.83210.23
Change in Inventory
-1,125-1,077-224.63124.9659.57
Change in Accounts Payable
516.37361.87155.61-150.46199.92
Change in Other Net Operating Assets
-78.54328.11272.3246.2-658.99
Operating Cash Flow
-125.73175.81745.94383.67170.48
Operating Cash Flow Growth
--76.43%94.42%125.05%1431.83%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-30.05-79.2-267.76-28.81-210.04
Sale of Property, Plant & Equipment
0.561.050.50.470.73
Sale (Purchase) of Intangibles
----0.68-0.13
Investment in Securities
-1.22.64-9.98-0-0
Other Investing Activities
65.2635.893.220.1810.93
Investing Cash Flow
34.58-39.62-274.01-28.84-198.51

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
217.9640.7859.18133.6724.31
Long-Term Debt Issued
54.0193.324.24-0.12
Total Debt Issued
271.98134.0883.42133.6724.43
Short-Term Debt Repaid
-101.41-0.35-32.08-8.51-102.63
Long-Term Debt Repaid
-10.55-12.18--2.62-
Total Debt Repaid
-111.97-12.53-32.08-11.13-102.63
Net Debt Issued (Repaid)
160.01121.5551.34122.54-78.2
Common Dividends Paid
-38.01-38.01-38.01-38.01-38.01
Other Financing Activities
-159.89-104.84-91.11-101.21-106.11
Financing Cash Flow
-37.88-21.3-77.78-16.68-222.32

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
-129.04114.9394.15338.15-250.36

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-155.7896.61478.18354.85-39.56
Free Cash Flow Growth
--79.80%34.76%--
Free Cash Flow Margin
-3.50%2.65%14.37%11.77%-1.42%
Free Cash Flow Per Share
-7.855.0825.1618.67-2.08
Levered Free Cash Flow
-627.38111.33332.4141.3697.65
Unlevered Free Cash Flow
-527.64173.2386.33201.14760.93

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
159.88104.8491.11101.21106.11
Cash Income Tax Paid
9.2810.843.49.2228.77
Change in Working Capital
-691.7-349.53230.95-98.13-189.27